Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Rheumatology Therapeutics Market Expected to Grow Between 2025 And 2029?
The market size for rheumatology therapeutics has seen consistent growth over the past few years. The current projection indicates an increase from $42.4 billion in 2024 to $44.18 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.2%. The historical growth can be credited to the increasing incidence of rheumatologic conditions, a growing aging population worldwide, heightened awareness of potential treatment solutions, progress in biological therapies, and the enhancement of healthcare availability in developing markets.
Anticipations indicate that the rheumatology therapeutics market will undergo steady expansion in the coming years. The market is predicted to reach $52.25 billion by 2029, growing at an annual average rate of 4.3%. This projected growth during the forecasted period can be credited to factors like the increasing switch to personalized medicine, growing utilization of biosimilars in rheumatology, an upsurge in research and development investment, the unification of digital health technologies, and accreditation for new therapies. Notable trends within this period encompass the proliferation of telemedicine and remote monitoring solutions, broadening of targeted treatments for specific rheumatic conditions, focus on patient-focused care models, widening of biologic treatments beyond monoclonal antibodies, and the embracing of value-based pricing models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Rheumatology Therapeutics Market?
The growth of the rheumatology therapeutics market is anticipated to be driven by the mounting occurrence of autoimmune diseases. These diseases have the characteristic where the immune system erroneously damages the body’s tissues. The increasing incidence of such diseases can be attributed to a mix of genetics, environmental influencers, lifestyle elements, enhanced awareness, and better diagnostic skills. Rheumatology therapeutics are vital in managing autoimmune diseases as they control inflammation, relieve symptoms, and prevent damage to joints and tissues caused by the immune system assaulting the body. For example, the Australian Institute of Health and Welfare estimated in June 2024 that around 514,000 individuals, accounting for 2.0% of the Australian population, were living with rheumatoid arthritis in 2022. This disease represented 2.0% of the entire disease load and 16% of the load for all musculoskeletal conditions in 2023. Therefore, due to the escalating incidence of autoimmune diseases, the rheumatology therapeutics market is witnessing growth.
Which Primary Segments of the Rheumatology Therapeutics Market Are Driving Growth and Industry Transformations?
The rheumatology therapeutics market covered in this report is segmented –
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications
Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Rheumatology Therapeutics Market?# Market?
North America was the largest region in the rheumatology therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Rheumatology Therapeutics Market?
The rheumatology therapeutics market is seeing significant developments by leading companies who are creating unique solutions such as intravenous (IV) formulations to improve treatment effectiveness and patient experience. IV formulations refer to drugs or substances delivered straight into a vein via a needle or tube. One notable development occurred in October 2023, when Swiss pharmaceutical company Novartis AG publicized they had received approval from the US Food and Drug Administration (FDA) for their IV formulation – Cosentyx. The specific form of Cosentyx is exclusively approved for treating adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). It functions by directly targeting and slowing down interleukin-17A (IL-17A) and is the sole non-tumor necrosis factor alpha (TNF-a) IV treatment option available for these ailments.
View the full report here:
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
What Parameters Are Used to Define the Rheumatology Therapeutics Market?
Rheumatology therapeutics encompass treatments aimed at managing and alleviating symptoms of rheumatic diseases, such as arthritis, lupus, and gout. These therapies include medications, such as anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs), and biologics, as well as physical therapy and lifestyle modifications. The goal is to reduce inflammation, control pain, and improve the quality of life for patients.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model